Notably, CHEK2 functions in the same DNA repair landscape as BRCA1, BRCA2, PALB2, and TP53, however, the ER and PR expression levels of CHEK2 tumor differ significantly from all other tumors, including PV and non-PV tumors. This evidence concerns the gene TP53 and acquired polycythemia vera.